Data Disclosure/Transfer Considerations
Agreements that outline the requirements for data transfer are required by AHS any time that health information where AHS is the custodian is being disclosed to a researcher (including data being disclosed as part of a data disclosure agreement [DDA]) and/or transferred to a third party. A number of agreements for data transfer can fulfill this need (i.e. a Clinical Trial Agreement (CTA), a sub-site agreement or a Data Transfer Agreement (DTA)).
Data Transfer Agreement (DTA): An inter-institutional or intra-institutional agreement to send data according to certain terms and conditions. DTA id
entify the parameters which govern the collection, transmission, storage, security, analysis, re-use, archiving, and destruction of data. A DTA should be developed in situations where the researcher has legal or ethical obligations, or where a real risk exists if the data is inappropriately accessed or used. Non-academic research activities (e.g., departmental/institution reporting, quality assurance, health services research, program evaluation) might also present the possibility of high risks of privacy or security breach and may require a DTA. The DTA binds the recipient party to Alberta Health Services. The sending party is not bound in the DTA but may be bound to their own responsibilities as part of a Data Disclosure Agreement (DDA).
Data Disclosure Agreement (DDA): An agreement between AHS and the principal investigator requesting personal health information from the data custodian (AHS). The agreement is signed to fulfill requirements set out as part of the Health Information Act (HIA).
A Data Transfer Agreement (DTA) is required when…
A Data Disclosure Agreement (DDA) is required when…
QUICK TIPS AND STRATEGIES FOR DATA DISCLOSURES/TRANSFERS
The AHS Health System Access team works with many administration partners to draft and execute Data Disclosure and Transfer Agreements. Please contact Research.Administration@ahs.ca to inquire about your data transfer request.